Research Overview
FOXO4-DRI is a synthetic peptide studied in research models involving cellular senescence, p53 signaling, apoptosis, longevity biology, and age-associated cellular mechanisms.
Designed to disrupt the interaction between FOXO4 and p53, FOXO4-DRI has become an important research peptide for investigating the molecular pathways that regulate senescent cell persistence, programmed cell death, and tissue homeostasis. Its targeted mechanism has positioned it as a valuable tool in the study of aging biology and cellular maintenance.
Lyophilized Vial Format
Precision-manufactured and lyophilized for stability, this research-grade peptide is produced to support reproducible laboratory workflows requiring accurate preparation, controlled storage, and consistent experimental performance.
Why Researchers Study FOXO4-DRI
FOXO4-DRI is investigated for its selective interaction with the FOXO4-p53 signaling axis, a pathway associated with the survival of senescent cells. By disrupting this protein-protein interaction, researchers are able to examine the biological mechanisms that influence cellular senescence, apoptosis, and tissue remodeling.
Its mechanism-driven profile has established FOXO4-DRI as a valuable research peptide for exploring senescence biology, genomic stability, regenerative processes, and the molecular networks involved in aging and cellular homeostasis.
Research Applications
Researchers commonly utilize FOXO4-DRI in laboratory investigations involving:
- Cellular senescence
- FOXO4-p53 signaling
- Apoptosis research
- Longevity biology
- Senolytic research
- Tissue homeostasis
- Cellular aging
- Genomic stability
- Regenerative biology
- Age-related disease models
